ELECSYS CA 125 II

Test, Epithelial Ovarian Tumor-associated Antigen (ca125)

BOEHRINGER MANNHEIM CORP.

The following data is part of a premarket notification filed by Boehringer Mannheim Corp. with the FDA for Elecsys Ca 125 Ii.

Pre-market Notification Details

Device IDK972162
510k NumberK972162
Device Name:ELECSYS CA 125 II
ClassificationTest, Epithelial Ovarian Tumor-associated Antigen (ca125)
Applicant BOEHRINGER MANNHEIM CORP. 9112 HAGUE RD. Indianapolis,  IN  46256
ContactLeeann Chambers
CorrespondentLeeann Chambers
BOEHRINGER MANNHEIM CORP. 9112 HAGUE RD. Indianapolis,  IN  46256
Product CodeLTK  
CFR Regulation Number866.6010 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1997-06-09
Decision Date1998-03-18
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.